※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.
07:30-08:10
- Satellite Symposium 5
-
- Venue:
- Halla Hall
- Enhancing Endocrine Therapy for Hormone Receptor-positive Advanced Breast Cancer
- Sung-Bae Kim (ASAN Medical Center, Korea)Slide ViewVideo ViewAbstract
08:00-09:30
- Practicing Breast Surgeons Session:
- Current Issues in Breast Clinic
- Venue:
- Weolla Room
- Role of KABTS in the Management of Breast Cancer in Korea
- Tae Ik Eom (Hiu Breast & Thyroid Clinic, Korea)Slide View
- Role of Ultrasound in Breast Cancer Screening
- Dongwon Kim (Daerim St. Mary's Hospital, Korea)Slide View
- BIRADS Categorization in Practice: Under or Over-categorization of Breast Lesions
- Hyewon Ro (Honest U Surgery Clinic, Korea)Slide View
- VABB in Breast Clinic
- Kyung Ho Cha (Mamma Breast Clinic, Korea)
- Current Issues in Breast Clinic
- Junho Kim (Dr. Kim Breast Thyroid Clinic, Korea)Slide View
08:30-09:30
- Plenary Lecture 5
-
- Venue:
- Halla Hall
09:40-10:50
- Symposium 5:
- To Treat or Not
- Venue:
- Halla Hall
- Survivorship Session:
- Advances in Breast Cancer Survivor's Care
- Venue:
- Lotus Hall
- Breast Cancer Survivorship Research and Care Practices from a Japanese Perspective
- Miyako Takahashi (National Cancer Center, Japan)Slide ViewVideo ViewAbstract
- Life after Breast Cancer in Australia
- Hyukjai Shin (Myongji Hospital, Medical School of Seonam Univ., Korea)Slide ViewVideo ViewAbstract
- Health Status and Healthcare Utilization of Breast Cancer Survivors
- Jihyoun Lee (Soonchunhyang Univ. Hospital Seoul, Korea)Slide ViewVideo ViewAbstract
- Oral Presentation 2
-
- Venue:
- Weolla Room
- GENETIC DETERMINANTS OF SPORADIC BREAST CANCER IN A COHORT OF SRI LANKAN POSTMENOPAUSAL WOMEN
- Nirmala Sirisena (Univ. of Colombo, Sri Lanka)Slide ViewAbstract
- LUMINAL ANDROGEN RECEPTOR AND ANDROGEN RECEPTOR-HIGH TRIPLE-NEGATIVE BREAST CANCERS ARE GENETICALLY SIMILAR TO LUMINAL BREAST CANCERS
- Jisun Kim (ASAN Medical Center, Korea)Slide ViewAbstract
- CIRCULATING TUMOR DNA PRESENTS VARIABLE CLONAL RESPONSE OF BREAST CANCER DURING NEOADJUVANT CHEMOTX
- Ji-Yeon Kim (Samsung Medical Center (Samsung Seoul Hospital), Korea)Slide ViewAbstract
- PREDICTIVE ROLE OF FCRR3A-158 POLYMORPHISM AND STROMAL TUMOR INFILTRATING LYMPHOCYTES IN PATIENTS WITH HER2 POSITIVE METASTATIC BREAST CANCER
- Heejung Chae (ASAN Medical Center, Korea)Slide ViewAbstract
- PHASE II STUDY OF APATINIB PLUS VINORELBINE, A NOVEL COMBINATION OF ALL-ORAL REGIMEN IN HEAVILY PRETREATED PATIENTS WITH METASTATIC HER2-NEGATIVE BREAST CANCER
- Anjie Zhu (Chinese Academy of Medical Science Pumc, China)Abstract
- BREAST CANCER TRENDS IN YOUNG WOMEN - A SINGAPOREAN PERSPECTIVE
- Yirong Sim (Singhealth Duke-nus Breast Centre, Singapore)Slide ViewAbstract
- RISK STRATIFICATION WITH ENDOPREDICT SIGNATURE FOR LUMINAL SUBTYPE BREAST CANCERS: RE-ANALYZING MICROARRAY EXPERIMENTS WITH HAN CHINESE ORIGIN
- Chi-Cheng Huang (Cathay General Hospital, Taiwan)Slide ViewAbstract
- INTRODUCING THE JAPANESE BREAST CANCER REGISTRY AND THE ACTIVITY
- Naoki Hayashi (St. Luke's International Hospital, Japan)Slide ViewAbstract
10:50-12:00
- Symposium 6:
- Personalized Therapy
- Venue:
- Halla Hall
- How to Interpret the Omics Big Data and Apply to the Clinical Practice
- Yu Shyr (Vanderbilt Univ. Medical Center, U.S.A.)Slide ViewVideo ViewAbstract
- Personalized Adjuvant Therapy Based on Clinical Trials in Breast Cancer: Dream or Reality?
- Martine Piccart (Institut Jules Bordet, Belgium)Slide ViewVideo ViewAbstract
- Where Are We Now, to the Precision Medicine
- Masakazu Toi (Kyoto Univ. Hospital, Japan)Slide ViewVideo ViewAbstract
- Education Session 3:
- Cell Cycle, CDKs and Breast Cancer: A Changing Paradigm
- Venue:
- Lotus Hall
- Cell Cycle Regulation and Targeting CDK 4/6 for Treatment of Breast Cancer
- Seock-Ah Im (Seoul National Univ., Korea)Video ViewAbstract
- CDK 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Clinical Data
- Jin-Hee Ahn (ASAN Medical Center, Korea)Slide ViewVideo ViewAbstract
- Ongoing Clinical Trials Combining CDK 4/6 Inhibitors and Related Biomarkers
- Soohyeon Lee (Pfizer Oncology, Korea)Slide ViewVideo ViewAbstract
- Oral Presentation 3
-
- Venue:
- Weolla Room
- EXOSOMAL DEL-1 AS A POTENT DIAGNOSTIC MARKER FOR BREAST CANCER: A PROSPECTIVE COHORT STUDY
- Soo Jung Lee (Kyungpook National Univ. School of Medicine, Korea)Slide ViewAbstract
- A SINGLE CENTER STUDY OF RISK REDUCING MANAGEMENT IN BRCA MUTATION CARRIERS AFTER DIAGNOSIS OF BREAST CANCER
- Hyokjo Kang (National Cancer Center, Korea)Abstract
- DNA METHYLATION PATTERNS OF CANCER TISSUES ASSOCIATED WITH BREAST CANCER SURVIVAL
- Choonghyun Ahn (Seoul National Univ. College of Medicine, Korea)Slide ViewAbstract
- MYBL1 REARRANGEMENTS AND MYB AMPLIFICATION IN BREAST ADENOID CYSTIC CARCINOMA LACKING THE MYB-NFIB FUSION GENE
- Jisun Kim (ASAN Medical Center, Korea)Slide ViewAbstract
- PREDICOTRS FOR COSMETIC OUTCOME IN ONCOPLASTIC MASTOPEXY TECHNIQUES
- Chin-Yau Chen (National Yang-ming Univ. Hospital, Taiwan)Slide ViewAbstract
- RANDOMIZED PHASE 2, OPEN-LABEL, DOSE-RANGING STUDY OF A NOVEL, LONG-ACTING G-CSF, EFLAPEGRASTIM (SPI-2012, ROLONTISTM) OR PEGFILGRASTIM FOR THE MANAGEMENT OF NEUTROPENIA IN PATIENTS WITH BREAST CANCER
- Gajanan Bhat (Spectrum Pharmaceuticals, U.S.A.)Slide ViewAbstract
- WNT-DP103-GSK3β CASCADE PROMOTES WNT/β-CATENIN SIGNALING IN PARENTAL AND STEM CELLS FROM TRIPLE NEGATIVE BREAST CANCER
- Alan Prem Kumar (National Univ. of Singapore, Singapore)Slide ViewAbstract
6Fl., squareME Bldg., 225 Bongeunsa-ro, Gangnam-gu, Seoul 06109, Korea 
+82-2-3452-7291 
+82-2-565-2434
gbcc@intercom.co.kr
www.gbcc.kr
